Abstract:ABSTRACT
Metformin is a first-line diabetes therapy but has one of the side effects which is a non-alcoholic fatty liver disease (NAFLD) that triggers the occurrence of fibrosis in the liver. Metformin nanoparticles can improve bioavailability and may reduce side effects. This study aims to analyze the effectiveness of metformin nanoparticle delivery through fasting blood glucose (FGB) levels and liver fibrosis in the diabetic rat model. This is experimental research with a post-test-only controlled grou… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.